(-)-(R)-Mianserin
CAS78684-63-6
(-)-(R)-Mianserin (CAS 78684-63-6, C18H20 N2) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 78684-63-6
- Formula
- C18H20 N2
- Mol. weight
- 264.36 g/mol
Chemical Specifications
Identifiers
| CAS number | 78684-63-6 |
|---|---|
| Product name | (-)-(R)-Mianserin |
| Synonyms | (-)-(R)-Mianserin; (R)-Mianserin; Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bR)- (9CI); Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (R)-; R-(-)-Mianserin |
| Molecular formula | C18H20 N2 |
| Molecular weight | 264.36 g/mol |
Physical and chemical properties
| Boiling Point | 186.1 ( ℃ ) |
|---|
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of (-)-(R)-Mianserin?
The CAS Registry Number of (-)-(R)-Mianserin is 78684-63-6. (-)-(R)-Mianserin is also known as (-)-(R)-Mianserin; (R)-Mianserin; Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bR)- (9CI).
What is the molecular formula and molecular weight of (-)-(R)-Mianserin?
The molecular formula of (-)-(R)-Mianserin is C18H20 N2, and its molecular weight is 264.36 g/mol.
How can I request a quotation for (-)-(R)-Mianserin?
Send an inquiry for (-)-(R)-Mianserin (CAS 78684-63-6) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for (-)-(R)-Mianserin
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.